Neuropeptides: opportunities for drug discovery

Publisher： Elsevier

ISSN： 1474-4422

Source： Lancet Neurology, Vol.2, Iss.8, 2003-08, pp. : 463-472

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuropeptides in Alzheimer's Disease: From Pathophysiological Mechanisms to Therapeutic Opportunities

Current Alzheimer Research, Vol. 10, Iss. 5, 2013-06 ,pp. : 449-468

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Functional Magnetic Resonance Imaging in Drug Discovery

By Paulus Martin Stein Murray

Neuropsychology Review, Vol. 17, Iss. 2, 2007-06 ,pp. : 179-188

Springer Publishing Company

Access to resources Recommend Favorite

Drug discovery for Alzheimer’s disease: The end of the beginning

By Refolo Lorenzo Fillit Howard

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 1-8

Humana Press, Inc

Access to resources Recommend Favorite

Strategies for Drug Discovery for Cognitive Aging and Alzheimer's Disease

By Fillit H.M. O'Connell A.W. Refolo L.M.

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 1-6

Humana Press, Inc

Access to resources Recommend Favorite

A New Model for Academics Based Drug Discovery

Current Alzheimer Research, Vol. 4, Iss. 5, 2007-12 ,pp. : 574-576

Bentham Science Publishers

Access to resources Recommend Favorite